DHEA Analog, Fluasterone, Entering Clinical Trials Tucson, AZ - Jan 14, 1997 While DHEA is lauded as possibly the nutritional supplement of the decade, Phase I clinical trials of a synthetic version believed to be more effective and without the side effects of the natural steroid begin in late Janua...

Carolinas Medical Center Joins STI in Developing Transplant Therapy for Diabetes Tucson, AZ - Nov 24, 1997 The Carolinas Medical Center in Charlotte, N.C. joins Sertoli Technologies Inc. as an investor and collaborator in advancing development of a proprietary transplant therapy for Type I, or insul...

1995 News Dec 11, 1995 RCT Forms Company to Develop Pharmaceuticals from Synthetic DHEA Recent News 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 2013 Research Corporation Technologies. All rights reserved. ...

RCT Forms Company to Develop Pharmaceuticals from Synthetic DHEA Tucson, AZ - Dec 11, 1995 Research Corporation Technologies (RCT) has formed Aeson Therapeutics Inc. to further ongoing development of therapeutic agents from a synthetic version of dehydroepiandrosterone, or DHEA. The patented DHEA an...

RCT and Royal Bank are Partners in Life Science Venture Firm, Milestone Medica Toronto, Ontario, Canada - Feb 10, 1998 David Shindler appointed Chief Executive Officer Milestone Medica Corporation, a recently formed venture development company specializing in early stage technology investment and ma...